SlideShare a Scribd company logo
Neoplasia
• Neoplasia literally means "new growth
• “A neoplasm is an abnormal mass of tissue,
the growth of which exceeds and is
uncoordinated with that of the normal tissues
and persists in the same excessive manner
after cessation of the stimuli which evoked
the change”
• Its often referred to as a tumor, and the study
of tumors is called oncology.
• Neoplasms can be of two types i.e. benign and
malignant
Basic Structure
• All tumors, benign and malignant, have two basic
components:
Parenchyma: made up of transformed or neoplastic cells,
• Largely determines its biologic behavior,
• Tumor derives its name.
Stroma: supporting, host-derived, non-neoplastic, made
up of connective tissue, blood vessels, and host-derived
inflammatory cells
• crucial to the growth of the neoplasm
- carries the blood supply
• provides support for the growth of parenchymal cells
Nomenclautre of neoplasia
Benign Tumors
• A tumor is said to be benign when its
microscopic and gross characteristics are
considered to be relatively innocent, remain
localized, non-metastatic and can be surgically
removed; the patient generally survives.
• Designated by attaching the suffix –oma
• Fibrous tissue: fibroma
• Cartilaginous tumor: chondroma
Benign Tumors
Adenoma
• benign epithelial neoplasms producing gland patterns
• derived from glands but not necessarily exhibiting gland
patterns
Papillomas
• Benign epithelial neoplasms, growing on any surface,
• Produce microscopic or macroscopic finger-like fronds
Polyp
• a mass that projects above a mucosal surface, as in the
gut, to form a macroscopically visible structure
Cystadenomas
• hollow cystic masses; typically they are seen in the ovary
Malignant Tumors
• lesion that can invade and destroy adjacent
structures and spread to distant sites
(metastasize) to cause death
Malignant neoplasms arising in
• Mesenchymal tissue : sarcomas
• Epithelial cell origin: carcinomas
• Glandular pattern: adenocarcinomas
Benign and Malignant Tumors
CHARACTERISTICS OF TUMORS
The characteristics of tumors are described
under the following headings
• Rate of growth
• Cancer stem cells
• Clinical and gross features
• Microscopic features
• Local invasion (Direct spread)
• Metastasis (Distant spread)
Rate of growth
• Generally proliferate more rapidly than the
normal cells.
• Benign tumors grow slowly and malignant
tumors rapidly
• Many exceptions to this generalization are
there.
• Rapidly growing tumors tend to be poorly
differentiated
Rate of growth
Cancer Stem Cells
• Cancer cell – heterogeneous population of cell
which may contain Cancer Stem Cells
• It has been hypothesized that these cells -
capacity to initiate and sustain the tumor
• So killing of these cells may be the principle of
certain therapies.
• Whether cancer stem cells exist in all tumors
is not yet clear
Cancer Stem Cells
Clinical Features
Benign
• Generally slow growing
• Depending upon the location
• Asymptomatic: subcutaneous lipoma
• Symptomatic: meningioma in the nervous
system
Malignant
• malignant tumors grow rapidly
• may ulcerate on the surface
• invade locally into deeper tissues
• may spread to distant sites (metastasis)
• systemic features such as weight loss, anorexia
and anemia
• cardinal clinical features : invasiveness and
metastasis
Gross appearance
Benign
• spherical or ovoid in shape
• encapsulated or well-circumscribed
• freely movable
• more often firm and uniform, unless secondary changes
like hemorrhages or infarction supervene
Malignant
• Irregular in shape
• poorly-circumscribed and extend into the adjacent tissues
• Secondary changes like hemorrhage, infarction and
ulceration are seen more often.
Gross appearance
Microscopic Features
Its of greatest importance for recognizing and
classifying the tumors.
These should be considered under
• Microscopic pattern
• Differentiation and anaplasia
• Tumor angiogenesis and stroma
• Inflammatory reaction
LOCAL INVASION (DIRECT SPREAD)
BENIGN TUMORS
• Form encapsulated or circumscribed masses
• Expand and push aside the surrounding normal tissues
• Without actually invading, infiltrating or metastasizing
MALIGNANT TUMORS
• Initially enlarge by expansion and some well-
differentiated tumors may be partially encapsulated as
well
• But later they can be distinguished by invasion,
infiltration and destruction of the surrounding tissue
METASTASIS (DISTANT SPREAD)
• Defined as the development of secondary
implants (metastasis) discontinuous with the
primary tumor, in remote tissues
• Benign tumors do not show metastasis
• Approximately 30% of newly diagnosed patients
with solid tumors (excluding skin cancers other
than melanomas) present with clinically evident
metastases
• An additional 20% have occult (hidden)
metastases at the time of diagnosis
Genetic theory of cancer: various gene regulate the
normal mechanism of growth in human body like
• Proto-oncogenes: growth-promoting genes
• Anti-oncogenes: growth-inhibiting or growth
suppressor genes.
• Apoptosis regulatory genes control the programmed
cell death.
• DNA repair genes
In cancer cell these are replaced by
• Activation of growth-promoting oncogenes
• Inactivation of cancer-suppressor genes
• Abnormal apoptosis regulatory genes
• Failure of DNA repair genes
Molecular pathogenesisofcancer
PHYSICALCARCINOGENESIS
• Radiation
– ultraviolet light and ionising radiation like X-rays, α-,
β- and γ-rays, radioactive isotopes, protons and
neutron
– Higher dose and with high LET(linear energytransfer)
causedcarcinogenic effect
• Non-radiation
– Continous mechanical injury to thetissues such
as from intrinsicstone
– implants of inert materials suchasplastic, glassetcin
prostheses
Chemical carcinogens and chemical
carcinogenesis
• Chemical carcinogens can be classified into
DIRECT-ACTING CARCINOGENS: do not require
metabolic activation
• Alkylating agents: various drugs (e.g.
cyclophosphamide, chlorambucil, busulfan,
melphalan, nitrosourea etc), β-propiolactone
and epoxides.
• Acylating agents: acetyl imidazole and
dimethyl carbamyl chloride
• INDIRECT-ACTING CARCINOGENS
(PROCARCINOGENS): prior metabolic activation
before becoming potent carcinogens.
• Polycyclic aromatic hydrocarbons: Anthracenes,
Benzapyrene, Methylcholanthrene
• Aromatic amines and azo-dyes: β-
naphthylamine, Benzidine
• Naturally-occurring products: Aflatoxin Bl,
Actinomycin D, Mitomycin C, Safrole, Betel nut
• Miscellaneous: Nitrosamines and nitrosamides,
Vinyl chloride monomer, Asbestos, Saccharin and
cyclomates,
BIOLOGICCARCINOGENESIS
Various studies have proved the direct role of
microorganisms in causing cancer.
• Parasites: Schistosoma haematobium - squamous
cell carcinoma of the urinary bladder
• Clonorchis sinensis, the liver fluke -
cholangiocarcinoma.
• Fungus: Aspergillus flavus (in certain grains) -
hepatocellular carcinoma.
• Bacteria: Helicobacter pylori - chronic gastritis
and peptic ulcer; its prolonged infection may
lead to gastric lymphoma and gastric carcinoma
Viral: most important organism
• Oncogenic RNA Viruses : human T-cell leukemia
virus-1 (HTLV-1) , retrovirus that has been
demonstrated to cause cancer in humans
• Oncogenic DNA Viruses : -human papillomavirus
(HPV), Epstein-Barr virus (EBV), Kaposi sarcoma
herpesvirus (KSHV) also called human
herpesvirus 8), and hepatitis B virus (HBV)
Clinical Implications
Local effects
1.Compression of nearby structures
Example includes pancreatic carcinoma on bile
duct leading to obstruction
2.Ulceration/bleeding
• Colon
• Gastric
• Renal cell carcinoma
3.Infection (often due to obstruction)
• Pneumonia
• Urinary infection
4.Rupture or infarction
• Ovarian
• Bladder
• Colon
Clinical Significance
Cancer Cachexia
• Progressive weakness, loss of appetite,
anemia and profound weight loss (>20%),
often correlate with tumor mass and spread.
• Probably related to macrophage production of
TNF-gamma.
Treatment of Cancer
• Most anti-cancer treatment is directed
towards killing actively dividing cells.
• Newer drugs target tumor cells by immune
mechanisms or hormones.
Treatment approaches
• Surgical therapy –early stage
• Chemotherapy
• Radiotherapy
• Neoadjuvant therapy –therapy in which
radiotherapy is applied first to reduce mass of
cells, once cells shrink it becomes easy to
remove them by surgical procedure.
Complications
• Minor aplasia
• Alopecia
• Sterility
• GIT damage
• Lung damage
• Kidney damage

More Related Content

Similar to Neoplasia.pptx

Principle of oncology
Principle of oncologyPrinciple of oncology
Principle of oncology
RajeevPandit10
 
oncology.ppt
oncology.pptoncology.ppt
oncology.ppt
LijFire
 
Neoplasia 2018.ppt
Neoplasia 2018.pptNeoplasia 2018.ppt
Neoplasia 2018.ppt
kevin90931
 
Neoplasia
NeoplasiaNeoplasia
Neoplasia
Sumanvijyanta
 
Oncology
OncologyOncology
neoplasia 1
 neoplasia  1 neoplasia  1
neoplasia 1
MINDS MAHE
 
10 neoplasia
10 neoplasia10 neoplasia
10 neoplasia
Lama K Banna
 
NEOPLASIA CLASS V NR (2).pptx
NEOPLASIA CLASS  V NR (2).pptxNEOPLASIA CLASS  V NR (2).pptx
NEOPLASIA CLASS V NR (2).pptx
elahinge1
 
ANTICANCER.ppt
ANTICANCER.pptANTICANCER.ppt
ANTICANCER.ppt
tesa10
 
Introduction to oncology
Introduction to oncologyIntroduction to oncology
Introduction to oncology
ABDUL QADEER MEMON
 
cancer, stages, symptoms
cancer, stages, symptomscancer, stages, symptoms
cancer, stages, symptoms
Shaifali Pandey
 
2 neoplasia (2).pptx
2 neoplasia (2).pptx2 neoplasia (2).pptx
2 neoplasia (2).pptx
MesfinShifara
 
Pathology Lecture - Neoplasia
Pathology Lecture - NeoplasiaPathology Lecture - Neoplasia
Pathology Lecture - Neoplasia
Shashidhar Venkatesh Murthy
 
Neoplasm
NeoplasmNeoplasm
Neoplasm
Samuel Asueme
 
Neoplasia 1
Neoplasia 1 Neoplasia 1
sugical oncology.pptx
sugical oncology.pptxsugical oncology.pptx
sugical oncology.pptx
LemiGebisa
 
Neplasia
NeplasiaNeplasia
Neplasia
Jomin George
 
cancer how when and what
cancer how when and whatcancer how when and what
cancer how when and what
Sarah Mohammed
 

Similar to Neoplasia.pptx (20)

Principle of oncology
Principle of oncologyPrinciple of oncology
Principle of oncology
 
neoplasia.pptx
neoplasia.pptxneoplasia.pptx
neoplasia.pptx
 
oncology.ppt
oncology.pptoncology.ppt
oncology.ppt
 
Neoplasia 2018.ppt
Neoplasia 2018.pptNeoplasia 2018.ppt
Neoplasia 2018.ppt
 
Neoplasia
NeoplasiaNeoplasia
Neoplasia
 
Oncology
OncologyOncology
Oncology
 
neoplasia 1
 neoplasia  1 neoplasia  1
neoplasia 1
 
10 neoplasia
10 neoplasia10 neoplasia
10 neoplasia
 
NEOPLASIA CLASS V NR (2).pptx
NEOPLASIA CLASS  V NR (2).pptxNEOPLASIA CLASS  V NR (2).pptx
NEOPLASIA CLASS V NR (2).pptx
 
ANTICANCER.ppt
ANTICANCER.pptANTICANCER.ppt
ANTICANCER.ppt
 
Introduction to oncology
Introduction to oncologyIntroduction to oncology
Introduction to oncology
 
cancer, stages, symptoms
cancer, stages, symptomscancer, stages, symptoms
cancer, stages, symptoms
 
2 neoplasia (2).pptx
2 neoplasia (2).pptx2 neoplasia (2).pptx
2 neoplasia (2).pptx
 
Pathology Lecture - Neoplasia
Pathology Lecture - NeoplasiaPathology Lecture - Neoplasia
Pathology Lecture - Neoplasia
 
Neoplasm
NeoplasmNeoplasm
Neoplasm
 
Neoplasia 1
Neoplasia 1 Neoplasia 1
Neoplasia 1
 
sugical oncology.pptx
sugical oncology.pptxsugical oncology.pptx
sugical oncology.pptx
 
Neplasia
NeplasiaNeplasia
Neplasia
 
Tumours
TumoursTumours
Tumours
 
cancer how when and what
cancer how when and whatcancer how when and what
cancer how when and what
 

More from NOKHAIZHAMMAD2021BSM

hematopoiesis-bhagyashree-180331211934.pdf
hematopoiesis-bhagyashree-180331211934.pdfhematopoiesis-bhagyashree-180331211934.pdf
hematopoiesis-bhagyashree-180331211934.pdf
NOKHAIZHAMMAD2021BSM
 
Developing a Conceptual Framework for Research (1).pptx
Developing a Conceptual Framework for Research (1).pptxDeveloping a Conceptual Framework for Research (1).pptx
Developing a Conceptual Framework for Research (1).pptx
NOKHAIZHAMMAD2021BSM
 
Ghjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggig
GhjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggigGhjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggig
Ghjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggig
NOKHAIZHAMMAD2021BSM
 
Patient Careghhgjhgwugwghjsghjsgjsghusvhgshg
Patient CareghhgjhgwugwghjsghjsgjsghusvhgshgPatient Careghhgjhgwugwghjsghjsgjsghusvhgshg
Patient Careghhgjhgwugwghjsghjsgjsghusvhgshg
NOKHAIZHAMMAD2021BSM
 
PN Lesson 12 Communicating with Patients.pptx
PN Lesson 12 Communicating with Patients.pptxPN Lesson 12 Communicating with Patients.pptx
PN Lesson 12 Communicating with Patients.pptx
NOKHAIZHAMMAD2021BSM
 
pptx (19).pptx
pptx (19).pptxpptx (19).pptx
pptx (19).pptx
NOKHAIZHAMMAD2021BSM
 
bloodcompositionanditsfunctionson17-170209014518.pdf
bloodcompositionanditsfunctionson17-170209014518.pdfbloodcompositionanditsfunctionson17-170209014518.pdf
bloodcompositionanditsfunctionson17-170209014518.pdf
NOKHAIZHAMMAD2021BSM
 
basicmeasurementsinepidemiology-201020073202.pdf
basicmeasurementsinepidemiology-201020073202.pdfbasicmeasurementsinepidemiology-201020073202.pdf
basicmeasurementsinepidemiology-201020073202.pdf
NOKHAIZHAMMAD2021BSM
 
SUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdf
SUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdfSUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdf
SUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdf
NOKHAIZHAMMAD2021BSM
 
Method of histological study L3.pptx
Method of histological study L3.pptxMethod of histological study L3.pptx
Method of histological study L3.pptx
NOKHAIZHAMMAD2021BSM
 
LEC 2 HISTO CELL MEMBRANE.pptx
LEC 2 HISTO CELL MEMBRANE.pptxLEC 2 HISTO CELL MEMBRANE.pptx
LEC 2 HISTO CELL MEMBRANE.pptx
NOKHAIZHAMMAD2021BSM
 
Death due to natural diseases.pdf
Death due to natural diseases.pdfDeath due to natural diseases.pdf
Death due to natural diseases.pdf
NOKHAIZHAMMAD2021BSM
 
hdnnonmlt-151222085444.pptx
hdnnonmlt-151222085444.pptxhdnnonmlt-151222085444.pptx
hdnnonmlt-151222085444.pptx
NOKHAIZHAMMAD2021BSM
 
bloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdf
bloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdfbloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdf
bloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdf
NOKHAIZHAMMAD2021BSM
 
bloodclotting-200418092606.pptx
bloodclotting-200418092606.pptxbloodclotting-200418092606.pptx
bloodclotting-200418092606.pptx
NOKHAIZHAMMAD2021BSM
 
Autopsy1.pdf
Autopsy1.pdfAutopsy1.pdf
Autopsy1.pdf
NOKHAIZHAMMAD2021BSM
 

More from NOKHAIZHAMMAD2021BSM (20)

hematopoiesis-bhagyashree-180331211934.pdf
hematopoiesis-bhagyashree-180331211934.pdfhematopoiesis-bhagyashree-180331211934.pdf
hematopoiesis-bhagyashree-180331211934.pdf
 
Developing a Conceptual Framework for Research (1).pptx
Developing a Conceptual Framework for Research (1).pptxDeveloping a Conceptual Framework for Research (1).pptx
Developing a Conceptual Framework for Research (1).pptx
 
Ghjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggig
GhjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggigGhjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggig
Ghjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggig
 
Patient Careghhgjhgwugwghjsghjsgjsghusvhgshg
Patient CareghhgjhgwugwghjsghjsgjsghusvhgshgPatient Careghhgjhgwugwghjsghjsgjsghusvhgshg
Patient Careghhgjhgwugwghjsghjsgjsghusvhgshg
 
PN Lesson 12 Communicating with Patients.pptx
PN Lesson 12 Communicating with Patients.pptxPN Lesson 12 Communicating with Patients.pptx
PN Lesson 12 Communicating with Patients.pptx
 
pptx (19).pptx
pptx (19).pptxpptx (19).pptx
pptx (19).pptx
 
pptx (19).pptx
pptx (19).pptxpptx (19).pptx
pptx (19).pptx
 
Hematopiosis.pptx
Hematopiosis.pptxHematopiosis.pptx
Hematopiosis.pptx
 
bloodcompositionanditsfunctionson17-170209014518.pdf
bloodcompositionanditsfunctionson17-170209014518.pdfbloodcompositionanditsfunctionson17-170209014518.pdf
bloodcompositionanditsfunctionson17-170209014518.pdf
 
pptx.pptx
pptx.pptxpptx.pptx
pptx.pptx
 
chap004.ppt
chap004.pptchap004.ppt
chap004.ppt
 
basicmeasurementsinepidemiology-201020073202.pdf
basicmeasurementsinepidemiology-201020073202.pdfbasicmeasurementsinepidemiology-201020073202.pdf
basicmeasurementsinepidemiology-201020073202.pdf
 
SUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdf
SUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdfSUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdf
SUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdf
 
Method of histological study L3.pptx
Method of histological study L3.pptxMethod of histological study L3.pptx
Method of histological study L3.pptx
 
LEC 2 HISTO CELL MEMBRANE.pptx
LEC 2 HISTO CELL MEMBRANE.pptxLEC 2 HISTO CELL MEMBRANE.pptx
LEC 2 HISTO CELL MEMBRANE.pptx
 
Death due to natural diseases.pdf
Death due to natural diseases.pdfDeath due to natural diseases.pdf
Death due to natural diseases.pdf
 
hdnnonmlt-151222085444.pptx
hdnnonmlt-151222085444.pptxhdnnonmlt-151222085444.pptx
hdnnonmlt-151222085444.pptx
 
bloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdf
bloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdfbloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdf
bloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdf
 
bloodclotting-200418092606.pptx
bloodclotting-200418092606.pptxbloodclotting-200418092606.pptx
bloodclotting-200418092606.pptx
 
Autopsy1.pdf
Autopsy1.pdfAutopsy1.pdf
Autopsy1.pdf
 

Recently uploaded

The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 

Recently uploaded (20)

The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 

Neoplasia.pptx

  • 2. • Neoplasia literally means "new growth • “A neoplasm is an abnormal mass of tissue, the growth of which exceeds and is uncoordinated with that of the normal tissues and persists in the same excessive manner after cessation of the stimuli which evoked the change” • Its often referred to as a tumor, and the study of tumors is called oncology. • Neoplasms can be of two types i.e. benign and malignant
  • 3. Basic Structure • All tumors, benign and malignant, have two basic components: Parenchyma: made up of transformed or neoplastic cells, • Largely determines its biologic behavior, • Tumor derives its name. Stroma: supporting, host-derived, non-neoplastic, made up of connective tissue, blood vessels, and host-derived inflammatory cells • crucial to the growth of the neoplasm - carries the blood supply • provides support for the growth of parenchymal cells
  • 5. Benign Tumors • A tumor is said to be benign when its microscopic and gross characteristics are considered to be relatively innocent, remain localized, non-metastatic and can be surgically removed; the patient generally survives. • Designated by attaching the suffix –oma • Fibrous tissue: fibroma • Cartilaginous tumor: chondroma
  • 6. Benign Tumors Adenoma • benign epithelial neoplasms producing gland patterns • derived from glands but not necessarily exhibiting gland patterns Papillomas • Benign epithelial neoplasms, growing on any surface, • Produce microscopic or macroscopic finger-like fronds Polyp • a mass that projects above a mucosal surface, as in the gut, to form a macroscopically visible structure Cystadenomas • hollow cystic masses; typically they are seen in the ovary
  • 7. Malignant Tumors • lesion that can invade and destroy adjacent structures and spread to distant sites (metastasize) to cause death Malignant neoplasms arising in • Mesenchymal tissue : sarcomas • Epithelial cell origin: carcinomas • Glandular pattern: adenocarcinomas
  • 9. CHARACTERISTICS OF TUMORS The characteristics of tumors are described under the following headings • Rate of growth • Cancer stem cells • Clinical and gross features • Microscopic features • Local invasion (Direct spread) • Metastasis (Distant spread)
  • 10. Rate of growth • Generally proliferate more rapidly than the normal cells. • Benign tumors grow slowly and malignant tumors rapidly • Many exceptions to this generalization are there. • Rapidly growing tumors tend to be poorly differentiated
  • 12. Cancer Stem Cells • Cancer cell – heterogeneous population of cell which may contain Cancer Stem Cells • It has been hypothesized that these cells - capacity to initiate and sustain the tumor • So killing of these cells may be the principle of certain therapies. • Whether cancer stem cells exist in all tumors is not yet clear
  • 14. Clinical Features Benign • Generally slow growing • Depending upon the location • Asymptomatic: subcutaneous lipoma • Symptomatic: meningioma in the nervous system
  • 15. Malignant • malignant tumors grow rapidly • may ulcerate on the surface • invade locally into deeper tissues • may spread to distant sites (metastasis) • systemic features such as weight loss, anorexia and anemia • cardinal clinical features : invasiveness and metastasis
  • 16. Gross appearance Benign • spherical or ovoid in shape • encapsulated or well-circumscribed • freely movable • more often firm and uniform, unless secondary changes like hemorrhages or infarction supervene Malignant • Irregular in shape • poorly-circumscribed and extend into the adjacent tissues • Secondary changes like hemorrhage, infarction and ulceration are seen more often.
  • 18. Microscopic Features Its of greatest importance for recognizing and classifying the tumors. These should be considered under • Microscopic pattern • Differentiation and anaplasia • Tumor angiogenesis and stroma • Inflammatory reaction
  • 19. LOCAL INVASION (DIRECT SPREAD) BENIGN TUMORS • Form encapsulated or circumscribed masses • Expand and push aside the surrounding normal tissues • Without actually invading, infiltrating or metastasizing MALIGNANT TUMORS • Initially enlarge by expansion and some well- differentiated tumors may be partially encapsulated as well • But later they can be distinguished by invasion, infiltration and destruction of the surrounding tissue
  • 20. METASTASIS (DISTANT SPREAD) • Defined as the development of secondary implants (metastasis) discontinuous with the primary tumor, in remote tissues • Benign tumors do not show metastasis • Approximately 30% of newly diagnosed patients with solid tumors (excluding skin cancers other than melanomas) present with clinically evident metastases • An additional 20% have occult (hidden) metastases at the time of diagnosis
  • 21. Genetic theory of cancer: various gene regulate the normal mechanism of growth in human body like • Proto-oncogenes: growth-promoting genes • Anti-oncogenes: growth-inhibiting or growth suppressor genes. • Apoptosis regulatory genes control the programmed cell death. • DNA repair genes In cancer cell these are replaced by • Activation of growth-promoting oncogenes • Inactivation of cancer-suppressor genes • Abnormal apoptosis regulatory genes • Failure of DNA repair genes
  • 23. PHYSICALCARCINOGENESIS • Radiation – ultraviolet light and ionising radiation like X-rays, α-, β- and γ-rays, radioactive isotopes, protons and neutron – Higher dose and with high LET(linear energytransfer) causedcarcinogenic effect • Non-radiation – Continous mechanical injury to thetissues such as from intrinsicstone – implants of inert materials suchasplastic, glassetcin prostheses
  • 24. Chemical carcinogens and chemical carcinogenesis • Chemical carcinogens can be classified into DIRECT-ACTING CARCINOGENS: do not require metabolic activation • Alkylating agents: various drugs (e.g. cyclophosphamide, chlorambucil, busulfan, melphalan, nitrosourea etc), β-propiolactone and epoxides. • Acylating agents: acetyl imidazole and dimethyl carbamyl chloride
  • 25. • INDIRECT-ACTING CARCINOGENS (PROCARCINOGENS): prior metabolic activation before becoming potent carcinogens. • Polycyclic aromatic hydrocarbons: Anthracenes, Benzapyrene, Methylcholanthrene • Aromatic amines and azo-dyes: β- naphthylamine, Benzidine • Naturally-occurring products: Aflatoxin Bl, Actinomycin D, Mitomycin C, Safrole, Betel nut • Miscellaneous: Nitrosamines and nitrosamides, Vinyl chloride monomer, Asbestos, Saccharin and cyclomates,
  • 26. BIOLOGICCARCINOGENESIS Various studies have proved the direct role of microorganisms in causing cancer. • Parasites: Schistosoma haematobium - squamous cell carcinoma of the urinary bladder • Clonorchis sinensis, the liver fluke - cholangiocarcinoma. • Fungus: Aspergillus flavus (in certain grains) - hepatocellular carcinoma. • Bacteria: Helicobacter pylori - chronic gastritis and peptic ulcer; its prolonged infection may lead to gastric lymphoma and gastric carcinoma
  • 27. Viral: most important organism • Oncogenic RNA Viruses : human T-cell leukemia virus-1 (HTLV-1) , retrovirus that has been demonstrated to cause cancer in humans • Oncogenic DNA Viruses : -human papillomavirus (HPV), Epstein-Barr virus (EBV), Kaposi sarcoma herpesvirus (KSHV) also called human herpesvirus 8), and hepatitis B virus (HBV)
  • 28. Clinical Implications Local effects 1.Compression of nearby structures Example includes pancreatic carcinoma on bile duct leading to obstruction 2.Ulceration/bleeding • Colon • Gastric • Renal cell carcinoma
  • 29. 3.Infection (often due to obstruction) • Pneumonia • Urinary infection 4.Rupture or infarction • Ovarian • Bladder • Colon
  • 30. Clinical Significance Cancer Cachexia • Progressive weakness, loss of appetite, anemia and profound weight loss (>20%), often correlate with tumor mass and spread. • Probably related to macrophage production of TNF-gamma.
  • 31. Treatment of Cancer • Most anti-cancer treatment is directed towards killing actively dividing cells. • Newer drugs target tumor cells by immune mechanisms or hormones.
  • 32. Treatment approaches • Surgical therapy –early stage • Chemotherapy • Radiotherapy • Neoadjuvant therapy –therapy in which radiotherapy is applied first to reduce mass of cells, once cells shrink it becomes easy to remove them by surgical procedure.
  • 33. Complications • Minor aplasia • Alopecia • Sterility • GIT damage • Lung damage • Kidney damage